164 related articles for article (PubMed ID: 9374241)
1. Neuroprotection of the optic nerve in glaucoma.
Caprioli J
Acta Ophthalmol Scand; 1997 Aug; 75(4):364-7. PubMed ID: 9374241
[No Abstract] [Full Text] [Related]
2. Neuroprotection: a new treatment modality for glaucoma?
Schwartz M; Yoles E
Curr Opin Ophthalmol; 2000 Apr; 11(2):107-11. PubMed ID: 10848215
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection: is it already applicable to glaucoma therapy?
Ritch R
Curr Opin Ophthalmol; 2000 Apr; 11(2):78-84. PubMed ID: 10848224
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of neuroprotection and applications in ocular disease.
Eur J Ophthalmol; 1999; 9 Suppl 1():S52-81; quiz S82-4. PubMed ID: 10230609
[No Abstract] [Full Text] [Related]
5. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
6. [The strategies for optic never protection in glaucoma patients].
Pang IH; Li B; Clark AF
Zhonghua Yan Ke Za Zhi; 2004 Nov; 40(11):783-7. PubMed ID: 15634490
[No Abstract] [Full Text] [Related]
7. Neuroprotection: A versatile approach to combat glaucoma.
Naik S; Pandey A; Lewis SA; Rao BSS; Mutalik S
Eur J Pharmacol; 2020 Aug; 881():173208. PubMed ID: 32464192
[TBL] [Abstract][Full Text] [Related]
8. Molecular and cell-based approaches for neuroprotection in glaucoma.
Lebrun-Julien F; Di Polo A
Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection in glaucoma using calpain-1 inhibitors: regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therapeutics.
Govindarajan B; Laird J; Sherman R; Salomon RG; Bhattacharya SK
CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):295-304. PubMed ID: 18673213
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection: the next breakthrough in glaucoma? Proceedings of the Third Annual Optic Nerve Rescue and Restoration Think Tank.
Chew SJ; Ritch R
J Glaucoma; 1997 Aug; 6(4):263-6. PubMed ID: 9264307
[No Abstract] [Full Text] [Related]
11. [The structure of the optic nerve in experimental glaucoma and in the means for its treatment].
Ivanova VF; Mikheeva EA; Karelina VE; Alekseev VN
Morfologiia; 2000; 117(2):56-61. PubMed ID: 10853253
[TBL] [Abstract][Full Text] [Related]
12. Optic nerve degeneration and potential neuroprotection: implications for glaucoma.
Schwartz M; Yoles E
Eur J Ophthalmol; 1999; 9 Suppl 1():S9-11. PubMed ID: 10230599
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective therapies for glaucoma.
Song W; Huang P; Zhang C
Drug Des Devel Ther; 2015; 9():1469-79. PubMed ID: 25792807
[TBL] [Abstract][Full Text] [Related]
14. [Modern pathogenetic-therapeutic approaches in glaucoma].
Constantin C; Costin D; Chiseliţă D
Oftalmologia; 1999; 49(4):13-7. PubMed ID: 11021280
[TBL] [Abstract][Full Text] [Related]
15. Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture.
Schwartz M
Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1407-11. PubMed ID: 12657572
[No Abstract] [Full Text] [Related]
16. Optic nerve and neuroprotection strategies.
Osborne NN; Chidlow G; Layton CJ; Wood JP; Casson RJ; Melena J
Eye (Lond); 2004 Nov; 18(11):1075-84. PubMed ID: 15534592
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potentials of aspirin in glaucomatous optic neuropathy.
Attarzadeh A; Hosseini H; Nowroozizadeh S
Med Hypotheses; 2006; 67(2):375-7. PubMed ID: 16527427
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection in Glaucoma.
Sigireddi RR; Frankfort BJ
Int Ophthalmol Clin; 2018; 58(3):51-67. PubMed ID: 29870410
[No Abstract] [Full Text] [Related]
19. Current and emerging medical therapies in the treatment of glaucoma.
Bagnis A; Papadia M; Scotto R; Traverso CE
Expert Opin Emerg Drugs; 2011 Jun; 16(2):293-307. PubMed ID: 21406029
[TBL] [Abstract][Full Text] [Related]
20. [Pay attention to the secondary optic neuropathy and the safe appropriate applications of optic neuroprotection].
Zhong Y
Zhonghua Yan Ke Za Zhi; 2016 Dec; 52(12):881-884. PubMed ID: 27998451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
